Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation
January 16, 2024
A recent study analyzing data from four pivotal clinical trials鈥擫EADER, STEP 2, SUSTAIN 6, and PIONEER 6鈥攅valuated the impact of concomitant metformin use on gastrointestinal adverse events during the initiation and titration of glucagon-like peptide 1 receptor agonists (GLP-1RA). Klara Klein, MD, PhD, assistant professor of medicine in the 黑料网...